IBB


Foamix (FOMX): A Beaten-Down Biotech Stock That Looks Like a Bargain Now

Get ready, bargain shoppers. Foamix (FOMX) has plummeted 27% since the beginning of the year and it looks like the stock received more …

Biotech Stocks Will Likely Be the Surprise Big Winner Once Again

By Steve Sjuggerud The last truly great “Melt Up” in U.S.

What Spooked vTv Therapeutics (VTVT) and Selecta Biosciences (SELB) Investors

vTv Therapeutics Collapses as Alzheimer’s Disease Drug Missed Primary Endpoint It’s a short and dramatic plunge for vTv Therapeutics Inc (NASDAQ:VTVT). Today, the drug …

Trump’s Next Target: Taking on the Biopharma Industry

In his first press conference upon winning the presidency, on Wednesday, Trump went up to bat against who he deems public enemy #1: …

iShares NASDAQ Biotechnology Index (ETF) (IBB): Can Biotech’s Trump Bump Last?

In the weeks since Donald Trump’s presidential election victory, the stock markets have ridden a wave into positive—and in the case of the …

Stock Update (NASDAQ:NVCN): Here’s Why Neovasc Inc (US) Shares Are Skyrocketing Over 100% Today

Neovasc Inc (US) (NASDAQ:NVCN) investors are overwhelmingly excited today after the medical device maker announced that Boston Scientific Corporation (NYSE:BSX) has agreed to acquire …

The Week Ahead in Life Sciences

Aug 2: Xencor Inc (NASDAQ:XNCR) – Q2 earnings released after market close, conf call at 1.30pm PDT.

Brexit: Biopharma Analysts Need to be Geopolitical Experts Too Now?

By Joshua E. Schimmer of Piper Jaffray With global markets being roiled by the apparently xenophobic and nationalistic fueled UK Brexit ‘Leave’ vote and …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts